Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
주식 순위 #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
주가
$44.42
마지막 동기화: 2026-08-25
시가총액
$5.90B
변동 (1일)
2.66%
변동 (1년)
344.66%
국가
US
거래 Definium Therapeutics, Inc. (DFTX)

카테고리

Definium Therapeutics, Inc. (DFTX)의 주가 이력
최고 종가: $44.49 (2026-08-01 기준)

최저 종가: $4.81 (2016-11-01 기준)
Definium Therapeutics, Inc.의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 65.08%
2025 74.98%
2024 107.98%
2023 34.70%
2022 -89.90%
2021 -40.72%
2020 7,946.66%
2019 -31.09%
2018 -81.58%
2017 -37.50%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.63 -12.26%
AU
$772.27 7.33%
CH